USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -11.45 Million | 29.88 Million |
Net Income | - | - | - | - | -214.98 Million | 5.11 Million |
Depreciation & Amortization | - | - | - | - | 8.2 Million | 16.45 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | -2.37 Million | 20.77 Million |
Other non-cash items | - | - | - | - | 197.69 Million | -12.45 Million |
Investing Cash Flow | - | - | - | - | 13.52 Thousand | -2623.00 |
Investments in PPE | - | - | - | - | - | -2623.00 |
Acquisitions | - | - | - | - | 13.52 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 13.52 Thousand | - |
Financing Cash Flow | - | - | - | - | 8.39 Million | -37.96 Million |
Debt repayment | - | - | - | - | -8.89 Million | -213.96 Thousand |
Dividends payments | - | - | - | - | -499.63 Thousand | -1.9 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 8.89 Million | -36.05 Million |
Accounts receivables | - | - | - | - | -3.65 Million | 17.8 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 1.28 Million | 2.97 Million |
Cash at beginning of period | - | - | - | - | 3.05 Million | 11.14 Million |
Cash at end of period | - | - | - | - | 73.3 Thousand | 3.05 Million |
Capital Expenditure | - | - | - | - | - | -2623.00 |
Effect of forex changes on cash | - | - | - | - | 67.49 Thousand | -7957.00 |
Net cash flow / Change in cash | - | - | - | - | -2.97 Million | -8.09 Million |
Free Cash Flow | - | - | - | - | -11.45 Million | 29.87 Million |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2017 Q2 | 2017 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -5.25 Million | -446.63 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | 4.42 Million | 875.63 Thousand |
Investing Cash Flow | - | - | - | - | 1982.00 | 18.00 |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 1982.00 | 18.00 |
Financing Cash Flow | - | - | - | - | 455.38 Thousand | -387.00 |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 455.38 Thousand | -387.00 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | 55.94 Thousand | 60.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 55.94 Thousand | 60.00 |
Free Cash Flow | - | - | - | - | -401.42 Thousand | 429.00 |
EQBK
LSR
CR9
ZYT
1905
COA